ARX vs EYE

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

ARX

AROA BIO FPO [ARX]

57MEDIUM

EYE

NOVA EYE FPO [EYE]

57MEDIUM

Score Breakdown

ARX EYE
Technical
38
57
Catalyst
50
53
Sentiment
50
50
Fundamental
95
76
Momentum
55
39
Risk Gate
50
45

Key Metrics

ARX Metric EYE
$202.9MMarket Cap$32.8M
314KAvg Volume (20d)269K
N/AShort InterestN/A
$0.80052-Week High$0.205
$0.49552-Week Low$0.100
-0.8%Daily Change+0.0%
$0.580Reference Price$0.115
+4.9%ROE-42.4%
+4.5%Profit Margin-21.3%

Active Signals

ARX Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Above-average volume (1.6x) on a red day — sellers in control
●Sitting near support — this level has held before and could attract buyers again
●Drifting lower — down 3.3% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (2.0x)

EYE Signals

●MACD momentum is picking up steam
●Stochastic is stretched into overbought — could need a breather
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Low P/S ratio (1.0x)
●Strong revenue growth (+29%)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare ARX and EYE in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ARX vs MVP →ARX vs CGS →EYE vs MVP →CGS vs EYE →CGS vs MVP →
ARX Full Analysis → EYE Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).